Depuy Hip Replacements

Johnson & Johnson gets another warning from FDA

According to a Bloomberg report, federal regulators have warned Johnson & Johnson’s consumer product division about a number of violations, including the company’s failure to properly review more than 60 medical complaints about a vaginal moisturizer product.

A letter from the U.S. Food and Drug Administration warns that Johnson & Johnson’s McNeil unit received 227 complaints during a seven-month period about its K-Y Liquidbeads, including 68 unspecified medical complaints that were ...

continue reading...

Consumer advocates: Congress missing opportunity

Some consumer groups are complaining about legislation that recently passed in the U.S. Senate, accusing Congress of passing up an opportunity to keep unsafe medical devices off the market – such as DePuy Orthopaedics all-metal artificial hip joints, and transvaginal mesh implants.

The bill, which regulates funding of the U.S. Food and Drug Administration, passed the Senate ...

continue reading...

Complications possible with hip replacement

According to the Mayo Clinic, hip replacement surgery is generally safe. But as with any surgery, complications can occur. Some complications are serious. But fortunately, most can be treated successfully.

Potential complications from hip replacement include:

  • Blood clots: Clots can form in leg veins as a result of decreased movement after surgery, as well as from pressure on the veins during surgery. Doctors usually give blood-thinning medications after surgery to try to ...
continue reading...

FDA panel votes against Xarelto because information missing

A U.S. Food and Drug Administration advisory panel has voted against approving Johnson & Johnson’s blood thinner Xarelto for prevention of blood clots in people with acute coronary syndrome.

According to U.S. News and World Report, the 6-to-4 decision came as a surprise because an FDA briefing document filed Monday in advance of the ruling gave the drug a favorable assessment.

But panel members reportedly said company studies did not provide enough ...

continue reading...

Investment advisor faults medical device makers

In a Motley Fool article for MSNBC, Sara Wright recommends against investing in manufacturers of dangerous medical devices that made it onto the market through a regulatory loophole.

“I cannot see clear to investing my money in companies that do not take the safety and efficacy of their products more seriously,” she writes.

Among the companies she spotlights are Johnson & Johnson, owner of a subsidiary that made read more.... --> continue reading...

Full-page ad calls for closing loophole

Consumers Union, the policy and advocacy arm of Consumer Reports, has placed a full-page print ad in Washington, D.C.-based publication Politico, calling on Congress to close a loophole that allows dangerous devices to make it on the market without clinical testing.

The ad is running as the U.S. Senate prepares to vote on a bill this week to reauthorize the statute governing medical device oversight.

It specifically makes reference to two medical ...

continue reading...
Page 25 of 32 «...10202324252627...»